source
- City Therapeutics raises $200M in IPO to fund thromboembolic disease pipelineCity Therapeutics, an RNA interference biotech focused on thromboembolic diseases, completed an initial public offering that raised $200 million. The company sold about 11 million shares at $18 ea…
- Lidl US recalls Gelatelli Coffee & Vanilla Gelato over possible Listeria contaminationLidl US announced a recall of one lot of its Gelatelli Coffee & Vanilla Gelato with coffee sauce and cookie pieces, citing potential contamination with Listeria monocytogenes. The affected product…